Results 61 to 70 of about 1,653 (153)

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer

BMC Cancer, 2019
Background Stereotactic irradiation (SBRT) is a standard of care for inoperable stage I lung cancer and brain oligometastases from lung cancer but is controversial for extracranial oligometastases.
Manon Kissel, Isabelle Martel-Lafay, Justine Lequesne, Jean-Christophe Faivre, Cécile Le Péchoux, Dinu Stefan, Victor Barraux, Cédric Loiseau, Jean-Michel Grellard, Serge Danhier, Delphine Lerouge, Christos Chouaid, Radj Gervais, Juliette Thariat   +13 more
doaj   +1 more source

sj-jpg-2-tam-10.1177_17588359231156387 – Supplemental material for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC

, 2023
Supplemental material, sj-jpg-2-tam-10.1177_17588359231156387 for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC by Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li and Shun ...
Yongfeng Yu (5883800), Lan Shen (381473), Huayan Huang (8067056), Ziming Li (402892), Wendi Xuzhang (14719390), Shun Lu (402894)   +5 more
core   +1 more source

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, Volume 2, Issue 1, Page 157-180, March 2026.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

sj-jpg-4-tam-10.1177_17588359231156387 – Supplemental material for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC

, 2023
Supplemental material, sj-jpg-4-tam-10.1177_17588359231156387 for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC by Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li and Shun ...
Yongfeng Yu (5883800), Lan Shen (381473), Huayan Huang (8067056), Ziming Li (402892), Wendi Xuzhang (14719390), Shun Lu (402894)   +5 more
core   +1 more source

Oligometastatic non-small-cell lung cancer: current treatment strategies

Lung Cancer: Targets and Therapy, 2016
Patrick J Richard, Ramesh Rengan Department of Radiation Oncology, University of Washington, Seattle, WA, USA Abstract: The oligometastatic disease theory was initially described in 1995 by Hellman and Weichselbaum.
Richard PJ, Rengan R
doaj  

Artificial Intelligence–Guided Clinical Decision Support for Immunotherapy in Advanced Hepatocellular Carcinoma: From Benefit–Risk Stratification to Adaptive Management

International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Immune checkpoint inhibitor–based regimens have become central to the systemic management of advanced hepatocellular carcinoma (HCC). Nevertheless, substantial heterogeneity persists in treatment efficacy, duration of response, toxicity, and preservation of liver function.
Tian Liang, Anchun Mo, Ke Su
wiley   +1 more source

sj-jpg-6-tam-10.1177_17588359231156387 – Supplemental material for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC

, 2023
Supplemental material, sj-jpg-6-tam-10.1177_17588359231156387 for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC by Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li and Shun ...
Yongfeng Yu (5883800), Lan Shen (381473), Huayan Huang (8067056), Ziming Li (402892), Wendi Xuzhang (14719390), Shun Lu (402894)   +5 more
core   +1 more source

Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Interventional radiology (IR) is a rapidly evolving medical field that combines advanced imaging with minimally invasive techniques for both diagnosis and treatment. Interventional oncology (IO), a subspecialty of IR, focuses on the minimally invasive, image‐guided intervention for cancer and cancer‐related conditions.
Mohamed E. Abdelsalam, Kamran Ahrar, Rahul A. Sheth, Ketan Y. Shah, Steven Yevich, Varshana Gurusamy, Bruno C. Odisio, Alda L. Tam, Armeen Mahvash, Peiman Habibollahi   +9 more
wiley   +1 more source

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequencing. The 2025 Advanced Urologic Cancer Consensus Conference was convened to establish evidence‐based expert consensus recommendations for optimal management.
Rana R. McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Andrea Apolo, Michael B. Atkins, Rick Bangs, Kathryn E. Beckermann, Joaquim Bellmunt, Stephanie A. Berg, Mehmet A. Bilen, David Braun, Maria I. Carlo, Jason Efstathiou, Matthew Galsky, Petros Grivas, Shilpa Gupta, Naomi Haas, A. Ari Hakimi, Hans Hammers, Daniel Y. C. Heng, Michelle Hirsch, Gopakumar Iyer, Eric Jonasch, Vadim S. Koshkin, Oleksandr N. Kryvenko, Bryan Lewis, Roger Li, Surena Matin, Benjamin Maughan, David F. McDermott, Bradley McGregor, Joshua Meeks, Matthew Milowsky, Robert Motzer, Andrea Necchi, Dan Petrylak, Sima Porten, Thomas Powles, Brian Rini, Brian Shuch, Arlene Siefker‐Radtke, Guru Sonpavde, S. Srikala Sridhar, Cristina Suarez, Chad Tang, Abhishek Tripathi, Michiel S. Van Der Heijden, Martin Voss, Wenxin Xu, Tian Zhang, Jonathan Rosenberg, Toni K. Choueiri   +53 more
wiley   +1 more source

sj-jpg-3-tam-10.1177_17588359231156387 – Supplemental material for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC

, 2023
Supplemental material, sj-jpg-3-tam-10.1177_17588359231156387 for Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC by Wendi Xuzhang, Huayan Huang, Yongfeng Yu, Lan Shen, Ziming Li and Shun ...
Yongfeng Yu (5883800), Lan Shen (381473), Huayan Huang (8067056), Ziming Li (402892), Wendi Xuzhang (14719390), Shun Lu (402894)   +5 more
core   +1 more source